Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
Clinical trial NCT05231590 · COMPLETED
Trial details
- NCT number
- NCT05231590
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2022-04-14
- Enrollment
- 581
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.